Annual Drug Patent Expirations for RADICAVA+ORS Radicava Ors is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Mitsubishi Tanabe drug RADICAVA ORS appeared firs…
New patent for Mitsubishi Tanabe drug RADICAVA ORS Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generi…
New tentative approval for Teva Pharms drug eltrombopag Read Post »
Annual Drug Patent Expirations for TURALIO Turalio is a drug marketed by Daiichi Sankyo Inc and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent for Daiichi Sankyo drug TURALIO appeared first on DrugPaten…
Annual Drug Patent Expirations for OCALIVA Ocaliva is a drug marketed by Intercept Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Intercept Pharms drug OCALIVA appeared first …
New patent expiration for Intercept Pharms drug OCALIVA Read Post »
Annual Drug Patent Expirations for OCALIVA Ocaliva is a drug marketed by Intercept Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Intercept Pharms drug OCALIVA appeared first …
New patent expiration for Intercept Pharms drug OCALIVA Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generi…
New tentative approval for Amneal Pharms drug saxagliptin Read Post »
This chart shows the pharmaceutical companies with the most patents in Austria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Austria? Read Post »
Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. There are nine patents protecting this drug. This drug…
The post New patent for Global Blood drug OXBRYTA appeared first on DrugP…
Annual Drug Patent Expirations for ORIAHNN+%28COPACKAGED%29 Oriahnn (copackaged) is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are four…
The post New patent for Abbvie Inc drug ORIAHNN (COPACKAGED…
New patent for Abbvie Inc drug ORIAHNN (COPACKAGED) Read Post »
Annual Drug Patent Expirations for AIRDUO+RESPICLICK Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from four suppliers. There are sixteen…
The post New patent for Teva Pharm drug AIRDUO RESPICLICK appear…
New patent for Teva Pharm drug AIRDUO RESPICLICK Read Post »
Get new actionable insights and updates from BiotechBlog
